In October, we added 102 citations in DIDB, including 45 in vitro (with 19 articles published in October 2025) and 57 in vivo articles (with 27 articles published in October 2025).
3 NDAs approved by the FDA in August 2025, including donidalorsen (DAWNZERA), dordaviprone (MODEYSO), and ZONGERTINIB (HERNEXEOS) were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.